Heska Corporation (HSKA)
(Delayed Data from NSDQ)
$79.28 USD
+3.36 (4.43%)
Updated May 3, 2019 04:00 PM ET
After-Market: $79.10 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[HSKA]
Reports for Purchase
Showing records 21 - 40 ( 64 total )
Industry: Medical - Biomedical and Genetics
Everyone taking share in vet diagnostics? Doubtful, but Heska is - raise target to $48
Provider: Feltl & Company
Analyst: HAYNOR B
Industry: Medical - Biomedical and Genetics
Feltl Q1 2016 Veterinary Practice Survey 379 veterinarians
Provider: Feltl & Company
Analyst: HAYNOR B
Industry: Medical - Biomedical and Genetics
Heska beats handily, guidance misinterpreted - reiterate STRONG BUY, $43.00 target
Provider: Feltl & Company
Analyst: HAYNOR B
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Heska barking up the right tree - reiterate STRONG BUY, raise target to $43.00
Provider: Feltl & Company
Analyst: HAYNOR B
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Heska clearly on offense, ups guidance - reiterate STRONG BUY, PT to $41.00
Provider: Feltl & Company
Analyst: HAYNOR B
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Q1 roughly inline with our estimates, customer traction strong, up target to $37.00
Provider: Feltl & Company
Analyst: HAYNOR B
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Q4 results essentially inline, Henry Schein relationship started strong
Provider: Feltl & Company
Analyst: HAYNOR B
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Quarterly results were well ahead of expectations again, reiterate STRONG BUY
Provider: Feltl & Company
Analyst: HAYNOR B